Contribution of matrix, fusion, hemagglutinin, and large protein genes of the CAM-70 measles virus vaccine strain to efficient growth in chicken embryonic fibroblasts

Journal of Virology

Volumn 83, Issue 22, 2009, Pages 11645-11654

  Sharma, Luna Bhatta ^a   Ohgimoto, Shinji ^a   Kato, Seiichi ^a   Kurazono, Sekiko ^a   Ayata, Minoru ^a   Takeuchi, Kaoru ^b   Ihara, Toshiaki ^c   Ogura, Hisashi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c MIE NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAM 70 MEASLES VACCINE; CD150 ANTIGEN; COMPLEMENTARY DNA; HEMAGGLUTININ; HYBRID PROTEIN; MATRIX PROTEIN; MEASLES VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHICKEN; CONTROLLED STUDY; DRUG SYNTHESIS; EMBRYO; FIBROBLAST; FLOW CYTOMETRY; GENE SEQUENCE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CHICK EMBRYO; CLONING, MOLECULAR; DNA, RECOMBINANT; FIBROBLASTS; FLOW CYTOMETRY; GENES, VIRAL; HEMAGGLUTININS, VIRAL; HUMANS; MEASLES VACCINE; MEASLES VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

MEASLES VIRUS;

EID: 70350328580     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01110-09     Document Type: Article

References (48)

1. Afzal, M. A., G. D. Elliot, B. K. Rima, and C. Orvell. 1990. Virus and host cell-dependent variation in transcription of the mumps virus genome. J. Gen. Virol. 71:615-619.
2. Aversa, G., J. Carballido, J. Punnonen, C.-C. J. Chang, T. Hauser, B. G. Cocks, and J. E. de Vries. 1997. SLAM and its role in T-cell activation and Th cell responses. Immunol. Cell Biol. 75:202-205.
3. Bankamp, B., S. P. Kearney, X. Liu, W. J. Bellini, and P. A. Rota. 2002. Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay. J. Virol. 76:7073-7081. (Pubitemid 41246221)
4. Bankamp, B., G. Hodge, M. B. McChesney, W. J. Bellini, and P. A. Rota. 2008. Genetic changes that affect the virulence of measles virus in a rhesus macaque model. Virology 373:39-50.
5. Bankamp, B., J. M. Fontana, W. J. Bellini, and P. A. Rota. 2008. Adaptation to cell culture induces functional differences in measles virus proteins. Virol. J. 5:129-140.
6. Cathomen, T., B. Mrkic, D. Spehner, R. Drillien, R. Naef, J. Pavlovic, A. Aguzzi, M. A. Billeter, and R. Cattaneo. 1998. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17:3899-3908. (Pubitemid 28333976)
7. Cathomen, T., H. Y. Naim, and R. Cattaneo. 1998. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J. Virol. 72:1224-1234. (Pubitemid 28116907)
8. Cattaneo, R., G. Rebmann, A. Schmid, K. Baczko, V. ter Meulen, and M. A. Billeter. 1987. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 6:681-688.
9. Centers for Disease Control and Prevention. 2008. Progress toward measles elimination-Japan, 1999-2008. MMWR Morb. Mortal. Wkly. Rep. 57:1049-1052.
10. Centers for Disease Control and Prevention. 2008. Progress in global measles controls and mortality reduction, 2000-2007. MMWR Morb. Mortal. Wkly. Rep. 57:1303-1306.
11. Cocks, B. G., C.-C. J. Chang, J. M. Carballido, H. Yssel, J. E. de Vries, and G. Aversa. 1995. A novel receptor involved in T-cell activation. Nature 376:260-263.
12. Dorig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295-305. (Pubitemid 23320293)
13. Erlenhoefer, C., W. J. Wurzer, S. Loffler, S. Schneider-Schaulies, V. ter Meulen, and J. Schneider-Schaulies. 2001. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J. Virol. 75:4499-4505.
14. Escoffier, C., and D. Gerlier. 1999. Infection of chicken embryonic fibroblasts by measles virus: adaptation at the virus entry level. J. Virol. 73:5220-5224. (Pubitemid 29246791)
15. Fontana, J. M., B. Bankamp, W. J. Bellini, and P. A. Rota. 2008. Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus. Virology 374:71-81.
16. Griffin, D. E. 2007. Measles virus, p. 1551-1585. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 5th ed. Lippincott/The Williams & Wilkins Co., Philadelphia, PA.
17. Hirano, A., M. Ayata, A. H. Wang, and T. C. Wong. 1993. Functional analysis of matrix proteins expressed from cloned genes of measles virus variants that cause subacute sclerosing panencephalitis reveals a common defect in nucleocapsid binding. J. Virol. 67:1848-1853. (Pubitemid 23088356)
18. Hsu, E., C. Iorio, F. Sarangi, A. Khine, and C. Richardson. 2001. CDw150 (SLAM) is a receptor for lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology 279:9-21. (Pubitemid 34160994)
19. Kato, S., S. Ohgimoto, L. B. Sharma, S. Kurazono, M. Ayata, K. Komase, M. Takeda, K. Takeuchi, T. Ihara, and H. Ogura. 2009. Reduced ability of hemagglutinin of the CAM-70 measles virus vaccine strain to use receptors CD46 and SLAM. Vaccine 27:3838-3848.
20. Kobune, F., H. Sakata, and A. Sugiura. 1990. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64:700-705. (Pubitemid 20032685)
21. Lamb, R. A. 1993. Paramyxovirus fusion: a hypothesis for changes. Virology 197:1-11.
22. Leonard, V. H. J., P. L. Sinn, G. Hodge, T. Miest, P. Devaux, N. Oezguen, W. Braun, P. B. McCray Juniorperiod, M. B. McChesney, and R. Cattaneo. 2008. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J. Clin. Investig. 118:2448-2458.
23. Liszewski, M. K., T. W. Post, and J. P. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431-455.
24. Morita, Y., T. Suzuki, M. Shiono, M. Shiobara, M. Saitoh, H. Tsukagoshi, M. Yoshizumi, T. Ishioka, M. Kato, K. Kozawa, K. Tanaka-Taya, Y. Yasui, M. Noda, N. Okabe, and H. Kimura. 2007. Sequence and phylogenetic analysis of the nucleoprotein (N) gene in measles viruses prevalent in Gunma, Japan, in 2007. Jpn. J. Infect. Dis. 60:402-404.
25. Moyer, S. A., S. C. Baker, and S. M. Horikami. 1990. Host cell proteins required for measles virus reproduction. J. Gen. Virol. 71:775-783.
26. Naniche, D., G. Varior-Krishnan, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032. (Pubitemid 23277513)
27. Ohgimoto, K., S. Ohgimoto, T. Ihara, H. Mizuta, S. Ishido, M. Ayata, H. Ogura, and H. Hotta. 2007. Difference in production of infectious wild-type and vaccine viruses in monocyte-derived dendritic cells. Virus Res. 123:1-8. (Pubitemid 44762250)
28. Okafuji, T., T. Okafuji, M. Fujino, and T. Nakayama. 2006. Current status of measles in Japan: molecular and seroepidemiological studies. J. Infect. Chemother. 12:343-348.
29. Okuno, Y., S. Ueda, T. Kurimura, N. Suzuki, K. Yamanishi, K. Baba, and M. Takahashi. 1971. Studies on further attenuated live measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine. Biken J. 14:253-258.
30. Ozaki, T., Y. Matsui, Y. Kajita, and N. Nishimura. 2002. Clinical and serological studies on CAM-70 live attenuated measles vaccine: an 18-year survey at a pediatric clinic in Japan. Vaccine 20:2618-2622. (Pubitemid 34615604)
31. Parks, C. L., R. A. Lerch, P. Walpita, H.-P. Wang, M. S. Sidhu, and S. A. Udem. 2001. Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J. Virol. 75:910-920. (Pubitemid 32037293)
32. Reuter, T., B. Weissbrich, S. Schneider-Schaulies, and J. Schneider-Schaulies. 2006. RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription. J. Virol. 80:5951-5957. (Pubitemid 43849172)
33. Sidorenko, S. P., and E. A. Clark. 1993. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J. Immunol. 151:4614-4624.
34. Spielhofer, P., T. Bachi, T. Fehr, G. Christiansen, R. Cattaneo, K. Kaelin, M. A. Billeter, and H. Y. Naim. 1998. Chimeric measles viruses with a foreign envelope. J. Virol. 72:2150-2159. (Pubitemid 28100771)
35. Suryanarayana, K., K. Baczko, V. ter Meulen, and R. R. Wagner. 1994. Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J. Virol. 68:1532-1543.
36. Tahara, M., M. Takeda, and Y. Yanagi. 2005. Contributions of matrix and large protein genes of the measles virus Edmonston strain to growth in cultured cells as revealed by recombinant viruses. J. Virol. 79:15218-15225. (Pubitemid 43032304)
37. Tahara, M., M. Takeda, and Y. Yanagi. 2007. Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. J. Virol. 81:6827-6836. (Pubitemid 46986619)
38. Tahara, M., M. Takeda, Y. Shirogane, T. Hashiguchi, S. Ohno, and Y. Yanagi. 2008. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J. Virol. 82:4630-4637. (Pubitemid 351563699)
39. Takeda, M., K. Takeuchi, N. Miyajima, F. Kobune, Y. Ami, N. Nagata, Y. Suzaki, Y. Nagai, and M. Tashiro. 2000. Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74:6643-6647. (Pubitemid 30429834)
40. Takeda, M., S. Ohno, F. Seki, K. Hashimoto, N. Miyajima, K. Takeuchi, and Y. Yanagi. 2005. Efficient rescue of measles virus from cloned cDNA using SLAM-expressing Chinese hamster ovary cells. Virus Res. 108:161-165. (Pubitemid 40170344)
41. Takeda, M. 2008. Measles virus breaks through epithelial cell barriers to achieve transmission. J. Clin. Investig. 118:2386-2389.
42. Takeda, M., S. Ohno, M. Tahara, H. Takeuchi, Y. Shirogane, H. Ohmura, T. Nakamura, and Y. Yanagi. 2008. Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice. J. Virol. 82:11979-11984.
43. Tatsuo, H., N. Ono, K. Tanaka, and Y. Yanagi. 2000. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893-897. (Pubitemid 30664265)
44. Ueda, S., M. Takahashi, Y. Minekawa, T. Ogino, N. Suzuki, K. Yamanishi, K. Baba, and Y. Okuno. 1970. Studies on further attenuated live measles vaccine. I. Adaptation of measles virus to the chorioallantoic membrane of chick embryo and clinical tests on the strain. Biken J. 13:111-116.
45. Ueda, S., M. Takahashi, Y. Minekawa, T. Ogino, N. Suzuki, K. Yamanishi, K. Baba, and Y. Okuno. 1970. Studies on further attenuated live measles vaccine. II. Correlation between the titer of the vaccine, the antibody response and clinical reactions. Biken J. 13:117-120.
46. Wolfson, L. J., P. M. Strebel, M. Gacic-Dobo, E. J. Hoekstra, J. W. McFarland, and B. S. Hersh; Measles Initiative. 2005. Has the 2005 measles mortality reduction goal been achieved? A natural history modeling study. Lancet 369:191-200.
47. Yanagi, Y., N. Ono, H. Tatsuo, K. Hashimoto, and H. Minagawa. 2002. Measles virus receptor SALM (CD150). Virology 299:155-161. (Pubitemid 35356591)
48. Yanagi, Y., M. Takeda, and S. Ohno. 2006. Measles virus: cellular receptors, tropism and pathogenesis. J. Gen. Virol. 87:2767-2779.